Abgenix, Inc. (ABGX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Abgenix, Inc. (ABGX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (251)	7/5/2003 4:26:12 PM
From: Icebrg	Read Replies (1) of 590

>>ABGX plus their cash might make for an interesting pipe.>> Cash shouldn't be a major consideration at Amgen. Over the last three years they have generated between 1,5 and 2,5 billion USD per year and they held 4,7 billion in cash and short-term investments at the end of March. And with yearly revenues running at 5,5 billion dollars they will have to start getting choosy about what they put into their pipeline too. Small will not be beautiful in their eyes any more. They will however soon have to answer the question: "Where do we go from here? If the answer is "Into oncology" Abgenix might be considered a tasty bite. Otherwise not. I don't think they would consider to buy ABGX just because it is available and not too expensive. I still cannot see why they were in such a hurry to take over HuMax-IL15 from Genmab. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next